Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC 4.0Cell Biochemistry and Function

Glycolysis and Bone Formation: From Pathological Mechanisms to Regulatory Strategies

  1. 1School of Pharmacy Jiangxi University of Chinese Medicine Nanchang Jiangxi China
  2. 2Nanchang Medical College Nanchang China
  3. 3Key Laboratory of TCM Prevention and Treatment of Senile Disease Nanchang China

Abstract

Bone homeostasis is maintained by the balance between osteoblast‐mediated bone formation and osteoclast‐induced bone resorption, and reduced osteoblastic activity contributes to osteoporosis (OP) and other bone disorders. Energy metabolism, especially glycolysis, has emerged as a critical regulator of osteoblast function and bone formation, yet its integrated role in physiological and pathological bone metabolism remains to be systematically defined. Here, we summarize the multi‐faceted mechanisms by which glycolysis modulates bone formation: glucose metabolic shifts during osteoblast differentiation, provision of energy substrates and metabolic intermediates for osteoblastic activities, regulation of glycolytic enzyme expression via key signaling pathways (e.g., Wnt) and transcription factors (HIF‐1α, mTOR), and mediation of metabolism‐differentiation crosstalk by non‐coding RNAs, including microRNAs (miRNAs) and lncRNAs, through targeted glycolytic gene regulation. In OP, glycolytic remodeling exacerbates impaired bone formation, and targeting pivotal glycolytic nodes for metabolic reprogramming holds great promise for developing novel osteoanabolic therapies against bone diseases.

Significance Statement: Bone formation is an energy‐intensive process, yet the vital role of glycolysis in driving osteoblast function is often underestimated. This review elucidates how glucose metabolism fuels bone formation, serving not only as an energy source but also as a critical regulator of cell differentiation. We synthesize evidence linking specific metabolic enzymes and signaling networks to skeletal health and demonstrate how these pathways are disrupted in diseases like osteoporosis. This work is important because it establishes a clear framework connecting cellular metabolism to bone pathology. By identifying key metabolic nodes as therapeutic targets, we offer a roadmap for developing novel strategies to treat bone disorders through metabolic reprogramming.

Related

  1. Spatiotemporal Multi-Omics and Compartment-Resolved Metabolomic Analyses Reveal the Mechanisms and Core Regulatory Networks of Cuticular Wax Formation in Blueberry Fruits
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. From multifaceted mechanisms to targeted strategies: advances in PANoptosomes as regulatory hubs of PANoptosis in cancer.
    Yingying Zhao, Mianhua Wu
    Cell communication and signaling : CCSPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCPMC
  3. Lipidic α-synuclein fibrils catalyze the formation of pathological mature fibrils
    A. Stevenson, J. E. Dreier, N. Baumgartner +3
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  4. Biochemical Characteristics of the Vascular Microenvironment in Pathological Conditions and Precision Therapeutic Strategies
    LI Bo-Chao
    Shengwu huaxue yu shengwu wuli jinzhanPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationDOAJ
  5. Disease-guided targeted protein degradation and clearance: matching strategies to pathological protein states
    Tianyu Wang, Chenbo Ji, Tianyu Zhao
    Frontiers in medicinePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCEurope PMCPMC
BibTeX
@article{chao2026glycolysis,
  title = {{Glycolysis and Bone Formation: From Pathological Mechanisms to Regulatory Strategies}},
  author = {Suzhen Chao and Yili Zhou and Junjie Xia and Nuoping Wu and Shuyu Zhan and Liang Zhang and Bo Liu},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  month = nov,
  doi = {10.1002/cbf.70341},
  url = {https://doi.org/10.1002/cbf.70341},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Glycolysis and Bone Formation: From Pathological Mechanisms to Regulatory Strategies
AU  - Suzhen Chao
AU  - Yili Zhou
AU  - Junjie Xia
AU  - Nuoping Wu
AU  - Shuyu Zhan
AU  - Liang Zhang
AU  - Bo Liu
PY  - 2026
DA  - 2026/11/12
JO  - Cell Biochemistry and Function
DO  - 10.1002/cbf.70341
UR  - https://doi.org/10.1002/cbf.70341
AB  - Bone homeostasis is maintained by the balance between osteoblast‐mediated bone formation and osteoclast‐induced bone resorption, and reduced osteoblastic activity contributes to osteoporosis (OP) and other bone disorders. Energy metabolism, especially glycolysis, has emerged as a critical regulator of osteoblast function and bone formation, yet its integrated role in physiological and pathological bone metabolism remains to be systematically defined. Here, we summarize the multi‐faceted mechanisms by which glycolysis modulates bone formation: glucose metabolic shifts during osteoblast differentiation, provision of energy substrates and metabolic intermediates for osteoblastic activities, regulation of glycolytic enzyme expression via key signaling pathways (e.g., Wnt) and transcription factors (HIF‐1α, mTOR), and mediation of metabolism‐differentiation crosstalk by non‐coding RNAs, including microRNAs (miRNAs) and lncRNAs, through targeted glycolytic gene regulation. In OP, glycolytic remodeling exacerbates impaired bone formation, and targeting pivotal glycolytic nodes for metabolic reprogramming holds great promise for developing novel osteoanabolic therapies against bone diseases.  Significance Statement: Bone formation is an energy‐intensive process, yet the vital role of glycolysis in driving osteoblast function is often underestimated. This review elucidates how glucose metabolism fuels bone formation, serving not only as an energy source but also as a critical regulator of cell differentiation. We synthesize evidence linking specific metabolic enzymes and signaling networks to skeletal health and demonstrate how these pathways are disrupted in diseases like osteoporosis. This work is important because it establishes a clear framework connecting cellular metabolism to bone pathology. By identifying key metabolic nodes as therapeutic targets, we offer a roadmap for developing novel strategies to treat bone disorders through metabolic reprogramming.
SN  - 0263-6484
SN  - 1099-0844
ER  -